about
Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock.From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injuryThe effects of direct hemoperfusion using a polymyxin B-immobilized column in a pig model of severe Pseudomonas aeruginosa pneumoniaPolymyxin B versus colistin: an update.Treatment of endotoxaemia and septicaemia in the equine patient.Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column theraClinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumoniasThromboelastography may detect hypercoagulation in early sepsis and improve anticoagulation during extracorporeal treatments.Rat polymyxin b hemoperfusion model: preventive effect on renal tubular cell death in a rat cecal ligation and puncture model.Polymyxin B hemoperfusion in septic shock: nothing overmuch (Meden Agan)!Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis.The role of adjuvant immunomodulatory agents for treatment of severe influenza.Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant.The Roles of Continuous Renal Replacement Therapy in Septic Acute Kidney Injury.Adjunctive Therapies During Extracorporeal Membrane Oxygenation to Enhance Multiple Organ Support in Critically Ill Children.Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an "endotoxin severity score" needed?
P2860
Q33776933-DF7BC549-96F9-4EB9-AD4A-D175CBA9168FQ35358796-395D3780-7868-4411-8CC0-DB5F6D3AF346Q35891577-ACE77916-C10A-4646-AF5E-5A828321BE56Q37062892-E001FD04-DF9A-48F6-86B9-967CACCD3526Q38613051-94B7EF8D-B639-4F6A-B62C-68E9E8DE3AF8Q38906880-F3EDAF66-F6E2-4E9A-B9E8-9EB1EA8C97AEQ39336211-04D5F856-6AFF-4A33-B9C9-A60933F9409DQ42175122-96318F9F-BE3E-4DD4-AC01-1FAD4F9A855DQ42634230-242AEA49-952A-426C-A1FD-B7E9E7728266Q46070300-044F6F21-1025-4935-876A-A3636D365183Q46074305-A42AD821-64BE-45ED-A88B-F4B46EC72EC3Q47094703-85BEF456-8ACA-4EE3-9CCD-A40D32BC0259Q47343207-FB3AF187-A454-4122-BC5E-FD308EED88F1Q47554935-7CA2FA9B-C8A7-4C8F-AA6A-D4C2D3438060Q51561730-4FC886C8-4099-442A-AFB1-31A69E263A2FQ54383592-FC6FF141-7260-452D-BFFE-0E7FB0C15F96Q54936263-0E6D0259-7D83-45BA-B304-4AFEF5159106Q58771842-66CCEB62-79F7-4792-AF27-39E2CB5B31F7
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polymyxin B hemoperfusion: a mechanistic perspective.
@ast
Polymyxin B hemoperfusion: a mechanistic perspective.
@en
Polymyxin B hemoperfusion: a mechanistic perspective.
@nl
type
label
Polymyxin B hemoperfusion: a mechanistic perspective.
@ast
Polymyxin B hemoperfusion: a mechanistic perspective.
@en
Polymyxin B hemoperfusion: a mechanistic perspective.
@nl
prefLabel
Polymyxin B hemoperfusion: a mechanistic perspective.
@ast
Polymyxin B hemoperfusion: a mechanistic perspective.
@en
Polymyxin B hemoperfusion: a mechanistic perspective.
@nl
P2860
P921
P356
P1433
P1476
Polymyxin B hemoperfusion: a mechanistic perspective.
@en
P2093
David J Klein
P2860
P2888
P356
10.1186/CC13912
P5008
P577
2014-06-09T00:00:00Z
P5875
P6179
1016937351